Cyndeo Wealth Partners LLC Raises Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Cyndeo Wealth Partners LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 10.6% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 9,713 shares of the medical equipment provider's stock after purchasing an additional 927 shares during the period. Cyndeo Wealth Partners LLC's holdings in Intuitive Surgical were worth $4,810,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in ISRG. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $25,000. Parvin Asset Management LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter worth $26,000. Global Financial Private Client LLC raised its holdings in shares of Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after acquiring an additional 38 shares during the period. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at about $28,000. Finally, Hurley Capital LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $28,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

ISRG stock traded up $6.86 during trading on Monday, reaching $519.04. 1,513,774 shares of the company were exchanged, compared to its average volume of 1,675,177. The stock's 50 day moving average price is $526.57 and its 200 day moving average price is $538.46. Intuitive Surgical, Inc. has a 52-week low of $413.82 and a 52-week high of $616.00. The company has a market cap of $186.03 billion, a P/E ratio of 80.97, a PEG ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter in the prior year, the firm posted $1.50 EPS. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

ISRG has been the subject of several recent analyst reports. Robert W. Baird cut their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a "buy" rating in a research report on Monday, April 14th. Royal Bank of Canada reduced their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft lowered shares of Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their target price for the stock from $515.00 to $440.00 in a research note on Monday, June 9th. Finally, Truist Financial reduced their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $588.95.

Insider Activity

In other news, EVP Gary Loeb sold 1,700 shares of the stock in a transaction that occurred on Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the sale, the executive vice president now directly owns 2,245 shares in the company, valued at $1,152,089.10. This represents a 43.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the transaction, the director now owns 6,371 shares of the company's stock, valued at $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 4,998 shares of company stock worth $2,611,577 over the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.